INTERNATIONAL PATENT: CANBRIDGE PHARMACEUTICALS, INC. FILES APPLICATION FOR "DYSTROPHIN CONSTRUCTS AND METHODS OF USE THEREOF"

GENEVA, Nov. 5 -- CANBRIDGE PHARMACEUTICALS, INC. (139 Main Street, Suite 100Cambridge, MA 02142) filed a patent application (PCT/US2025/026535) for "DYSTROPHIN CONSTRUCTS AND METHODS OF USE THEREOF" on Apr 25, 2025. With publication no. WO/2025/227131, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEST, Jason, Allen (C/o Canbridge Pharmaceuticals, Inc.139 Main Street, Suite 100Cambridge, MA 02142), KENNEDY, Zachary, Corkin (C/o Canbridge Pharmaceuticals, Inc.139 Main Street, Suite 100Cambridge, MA 02142)

Abstract: The...